Viral load is the quantity of virus in a given amount of patient’s blood.
Synonyms
Virus load
Detailed description
This factor is mainly used to control the therapeutic process of infections with HIV, cytomegaly viruses, hepatitis A viruses and hepatitis B viruses. A high viral load correlates with a severe infection or a poor prognosis, respectively.
Scientists from the Bernhard Nocht Institute for Tropical Medicine (BNITM) and the Friedrich-Loeffler-Institut (FLI), both DZIF member establishments, have succeeded in identifying a novel bornavirus
In the EU project “EVIDENT”, scientists investigated around 180 patient samples from the Ebola epidemic in West Africa, to elucidate the origin of the epidemic in the individual countries and the
DZIF researchers at the LMU Munich have successfully tested their candidate vaccine against MERScoronavirus in a preclinical trial. Plans for a clinical trial, in which the virus will be tested in
Researchers at the University of Bonn and the German Center for Infection Research (DZIF) have discovered two new groups of viruses within the Bunyavirus family in the tropical forest of Ivory Coast
In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded
30 years after HIV was discovered to be the cause of the acquired immune deficiency syndrome AIDS, and despite intensive research, no vaccine or cure has yet been found. An international team of
The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available. At the Hamburg-Eppendorf University Medical Center (UKE), in Geneva
A patient who had contracted the dangerous MERScoronavirus in Abu Dhabi gave rise to public concern in Osnabrück this weekend. Many people fear a spread of the pathogen, which causes severe pneumonia
(26/11/2014) Virologist Stephan Urban from the University of Heidelberg will receive the DZIF Prize for Translational Infection Research, worth 5000 Euros. It will be awarded for the first time at the
Researchers at the University of Tübingen are testing an Ebolavaccine in healthy adults in Gabon. The first voluntary trial participants are being vaccinated today.
